Literature DB >> 1955373

c-Ki-ras point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas.

A Yanagisawa1, Y Kato, K Ohtake, T Kitagawa, K Ohashi, M Hori, K Takagi, H Sugano.   

Abstract

Ductectatic-type mucinous cystic neoplasms of the pancreas constitute a recently recognized new human pancreatic tumor entity. Examination for the presence of point mutations at codon 12 of K-ras by oligonucleotide hybridization in 5 adenomas and 3 carcinomas revealed alteration in 3 and 2, respectively. In 4 of these positive cases, the transition was GGT----GAT (Gly----Asp) with the remaining one, found in a cancer, being GGT----GTT (Gly----Val). In two carcinoma cases, the same point mutation was detected both in the carcinoma area and in a coexisting adenoma component. Thus K-ras point mutation appears to be associated with this particular type of neoplasm in the same manner as observed for typical exocrine pancreas carcinomas. Our study also indicates the possible existence of an adenoma-carcinoma sequence in the evolution of this type of neoplasm and we suggest that K-ras activation may be an important event in the phase of adenoma development.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1955373      PMCID: PMC5918253          DOI: 10.1111/j.1349-7006.1991.tb01756.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  12 in total

Review 1.  Cooperation between oncogenes.

Authors:  T Hunter
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

2.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

3.  KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas.

Authors:  V T Smit; A J Boot; A M Smits; G J Fleuren; C J Cornelisse; J L Bos
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

4.  Detection of activated c-H-ras oncogene in hepatocellular carcinomas developing in transgenic mice harboring albumin promoter-regulated simian virus 40 gene.

Authors:  G H Lee; H Li; K Ohtake; K Nomura; O Hino; Y Furuta; S Aizawa; T Kitagawa
Journal:  Carcinogenesis       Date:  1990-07       Impact factor: 4.944

5.  A dot-blot screening procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides.

Authors:  M Verlaan-de Vries; M E Bogaard; H van den Elst; J H van Boom; A J van der Eb; J L Bos
Journal:  Gene       Date:  1986       Impact factor: 3.688

Review 6.  Pancreatic cystic neoplasms.

Authors:  D Mathieu; B Guigui; P J Valette; T H Dao; J N Bruneton; J M Bruel; J Pringot; N Vasile
Journal:  Radiol Clin North Am       Date:  1989-01       Impact factor: 2.303

7.  High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas.

Authors:  K Grünewald; J Lyons; A Fröhlich; H Feichtinger; R A Weger; G Schwab; J W Janssen; C R Bartram
Journal:  Int J Cancer       Date:  1989-06-15       Impact factor: 7.396

8.  Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction.

Authors:  D K Shibata; N Arnheim; W J Martin
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

9.  Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients.

Authors:  M Mariyama; K Kishi; K Nakamura; H Obata; S Nishimura
Journal:  Jpn J Cancer Res       Date:  1989-07

10.  Frequent glycine-to-aspartic acid mutations at codon 12 of c-Ki-ras gene in human pancreatic cancer in Japanese.

Authors:  Y Nagata; M Abe; K Motoshima; E Nakayama; H Shiku
Journal:  Jpn J Cancer Res       Date:  1990-02
View more
  33 in total

1.  Detection of k-ras gene point mutation in fine needle aspiration and pancreatic juice by sequence special primer method and its clinical significance.

Authors:  Xun-Liang Liu; Cun-Cai Dai; Yi Miao; Jing-Hui Du; Zhao-Song Zhang; Shu-Zhen Chen
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

2.  Treatment strategy of intraductal papillary-mucinous tumor of the pancreas.

Authors:  Kenji Yamao
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

Review 3.  Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  Go Kobayashi; Naotaka Fujita; Yutaka Noda; Takashi Obana; Osamu Takasawa
Journal:  J Med Ultrason (2001)       Date:  2008-09-19       Impact factor: 1.314

Review 4.  K-ras mutation and pancreatic adenocarcinoma.

Authors:  C Caldas; S E Kern
Journal:  Int J Pancreatol       Date:  1995-08

Review 5.  Pathological and molecular evaluation of pancreatic neoplasms.

Authors:  Arvind Rishi; Michael Goggins; Laura D Wood; Ralph H Hruban
Journal:  Semin Oncol       Date:  2014-12-09       Impact factor: 4.929

6.  Mode of progression of intraductal papillary-mucinous tumor of the pancreas: analysis of patients with follow-up by EUS.

Authors:  Go Kobayashi; Naotaka Fujita; Yutaka Noda; Kei Ito; Jun Horaguchi; Osamu Takasawa; Satoshi Akaishi; Takashi Tsuchiya; Masao Kobari
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

7.  Telomerase activity in periampullary tumors correlates with aggressive malignancy.

Authors:  J H Balcom; T Keck; A L Warshaw; B Antoniu; F Graeme-Cook; C Fernández-del Castillo
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

Review 8.  Intraductal papillary mucinous tumors of the pancreas. Verona University Pancreatic Team.

Authors:  C Bassi; C Procacci; G Zamboni; A Scarpa; G Cavallini; P Pederzoli
Journal:  Int J Pancreatol       Date:  2000-06

9.  PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas.

Authors:  Frank Schönleben; Wanglong Qiu; Helen E Remotti; Werner Hohenberger; Gloria H Su
Journal:  Langenbecks Arch Surg       Date:  2008-02-21       Impact factor: 3.445

10.  Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma.

Authors:  Reena Shakya; Tamas Gonda; Michael Quante; Martha Salas; Samuel Kim; Jenna Brooks; Steffen Hirsch; Justine Davies; Angelica Cullo; Kenneth Olive; Timothy C Wang; Matthias Szabolcs; Benjamin Tycko; Thomas Ludwig
Journal:  Cancer Res       Date:  2012-11-29       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.